Untangling the intracellular signalling network in cancer - A strategy for data integration in acute myeloid leukaemia

Journal of Proteomics

Volumn 74, Issue 3, 2011, Pages 269-281

  Jørgensen, Katarina M ^a   Hjelle, Sigrun M ^a   Oye, Ola K ^b   Puntervoll, Pål ^a   Reikvam, Håkon ^a   Skavland, Jørn ^a   Anderssen, Endre ^c   Bruserud, Oystein ^a   Gjertsen, Bjørn Tore ^a,d  

^a UNIVERSITY OF BERGEN   (Norway)

^b CHRISTIAN MICHELSEN RESEARCH AS   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cancer biomarkers; Data integration; Genomics; Partial least squares regression; Proteomics

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CLASSIFICATION; CARCINOGENESIS; CELL COMMUNICATION; DRUG MEGADOSE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOME ANALYSIS; GENOMICS; HUMAN; INTRACELLULAR SIGNALING; MOLECULAR DYNAMICS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; TREATMENT RESPONSE;

CYTOKINES; DATABASES, PROTEIN; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; GENOMICS; HUMANS; LEUKEMIA, MYELOID, ACUTE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROTEOME; PROTEOMICS; REGRESSION ANALYSIS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78651479105     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2010.11.003     Document Type: Review

References (73)

1. Neoptolemos J.P., Cunningham D., Friess H., Bassi C., Stocken D.D., Tait D.M., et al. Adjuvant therapy in pancreatic cancer: historical and current perspectives. Ann Oncol 2003, 14:675-692.
2. Wouters B.J., Lowenberg B., Delwel R. A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects. Blood 2009, 113:291-298.
3. Saebo S., Almoy T., Flatberg A., Aastvelt A.H., Martens H. LPLS-regression: a method for prediction and classification under the influence of background information on predictor variables. Chemom Intell Lab Syst 2008, 91:121-132.
4. Panchaud A., Affolter M., Moreillon P., Kussmann M. Experimental and computational approaches to quantitative proteomics: status quo and outlook. J Proteomics 2008, 71:19-33.
5. Chari R., Thu K.L., Wilson I.M., Lockwood W.W., Lonergan K.M., Coe B.P., et al. Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer. Cancer Metastasis Rev 2010, 29:73-93.
6. Bullinger L., Armstrong S.A. HELP for AML: methylation profiling opens new avenues. Cancer Cell 2010, 17:1-3.
7. Barabasi A.L., Oltvai Z.N. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004, 5:101-113.
8. Estey E., Dohner H. Acute myeloid leukaemia. Lancet 2006, 368:1894-1907.
9. Lowenberg B. Acute myeloid leukemia: the challenge of capturing disease variety. Hematol Am Soc Hematol Educ Program 2008, 1-11.
10. Haferlach T., Bacher U., Kern W., Schnittger S., Haferlach C. Diagnostic pathways in acute leukemias: a proposal for a multimodal approach. Ann Hematol 2007, 86:311-327.
11. Mrozek K., Radmacher M.D., Bloomfield C.D., Marcucci G. Molecular signatures in acute myeloid leukemia. Curr Opin Hematol 2009, 16:64-69.
12. Kornblau S.M., Tibes R., Qiu Y.H., Chen W., Kantarjian H.M., Andreeff M., et al. Functional proteomic profiling of AML predicts response and survival. Blood 2009, 113:154-164.
13. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976, 33:451-458.
14. Lowenberg B., Ossenkoppele G.J., van Putten W., Schouten H.C., Graux C., Ferrant A., et al. High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med 2009, 361:1235-1248.
15. Schlenk R.F., Dohner K., Krauter J., Frohling S., Corbacioglu A., Bullinger L., et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008, 358:1909-1918.
16. Wang Z.Y., Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008, 111:2505-2515.
17. Stapnes C., Gjertsen B.T., Reikvam H., Bruserud O. Targeted therapy in acute myeloid leukaemia: current status and future directions. Expert Opin Investig Drugs 2009, 18:433-455.
18. Hande K.R. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer 1998, 34:1514-1521.
19. Latagliata R., Bongarzoni V., Carmosino I., Mengarelli A., Breccia M., Borza P.A., et al. Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon. Ann Oncol 2006, 17:281-285.
20. Anensen N., Oyan A.M., Bourdon J.C., Kalland K.H., Bruserud O., Gjertsen B.T. A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. Clin Cancer Res 2006, 12:3985-3992.
21. Oyan A.M., Anensen N., Bo T.H., Stordrange L., Jonassen I., Bruserud O., et al. Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia. BMC Cancer 2009, 9:77.
22. Seifert H., Mohr B., Thiede C., Oelschlagel U., Schakel U., Illmer T., et al. The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia. Leukemia 2009, 23:656-663.
23. Ishikawa Y., Kiyoi H., Tsujimura A., Miyawaki S., Miyazaki Y., Kuriyama K., et al. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia. Eur J Haematol 2009, 83:90-98.
24. Kruse J.P., Gu W. SnapShot: p53 posttranslational modifications. Cell 2008, 133:930-30 e1.
25. Toledo F., Wahl G.M. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006, 6:909-923.
26. Vousden K.H., Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009, 137:413-431.
27. Bruserud O., Gjertsen B.T., Foss B., Huang T.S. New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of AML cells-the present use in experimental studies and the possible importance for future therapeutic approaches. Stem Cells 2001, 19:1-11.
28. Bruserud O., Ryningen A., Olsnes A.M., Stordrange L., Oyan A.M., Kalland K.H., et al. Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica 2007, 92:332-341.
29. Irish J.M., Hovland R., Krutzik P.O., Perez O.D., Bruserud O., Gjertsen B.T., et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004, 118:217-228.
30. Irish J.M., Anensen N., Hovland R., Skavland J., Borresen-Dale A.L., Bruserud O., et al. Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53. Blood 2007, 109:2589-2596.
31. Tainsky M.A. Genomic and proteomic biomarkers for cancer: a multitude of opportunities. Biochim Biophys Acta 2009, 1796:176-193.
32. Shi L., Reid L.H., Jones W.D., Shippy R., Warrington J.A., Baker S.C., et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006, 24:1151-1161.
33. Bacher U., Kohlmann A., Haferlach T. Current status of gene expression profiling in the diagnosis and management of acute leukaemia. Br J Haematol 2009, 145:555-568.
34. Anensen N., Oyan A.M., Huseby S., Kalland K.H., Bruserud O., Gjertsen B.T. Early gene expression of acute myeloid leukemia in response to chemotherapy. Expert Rev Anticancer Ther 2007, 7:741-751.
35. Quackenbush J. Microarray analysis and tumor classification. N Engl J Med 2006, 354:2463-2472.
36. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
37. Boulesteix A.L., Porzelius C., Daumer M. Microarray-based classification and clinical predictors: on combined classifiers and additional predictive value. Bioinformatics 2008, 24:1698-1706.
38. Oyan A.M., Bo T.H., Jonassen I., Ulvestad E., Gjertsen B.T., Bruserud O., et al. Global gene expression in classification, pathogenic understanding and identification of therapeutic targets in acute myeloid leukemia. Curr Pharm Biotechnol 2007, 8:1-11.
39. Werner T. Regulatory networks: linking microarray data to systems biology. Mech Ageing Dev 2007, 128:168-172.
40. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550.
41. Falcon S., Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics 2007, 23:257-258.
42. Kohlmann A., Kipps T.J., Rassenti L.Z., Downing J.R., Shurtleff S.A., Mills K.I., et al. An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase. Br J Haematol 2008, 142:802-807.
43. Sjoholt G., Bedringaas S.L., Doskeland A.P., Gjertsen B.T. Proteomic strategies for individualizing therapy of acute myeloid leukemia (AML). Curr Pharm Biotechnol 2006, 7:159-170.
44. Koonin E.V., Wolf Y.I., Karev G.P. The structure of the protein universe and genome evolution. Nature 2002, 420:218-223.
45. Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., et al. The transcriptional landscape of the mammalian genome. Science 2005, 309:1559-1563.
46. Pearson H. Biologists initiate plan to map human proteome. Nature 2008, 452:920-921.
47. Leng S.X., McElhaney J.E., Walston J.D., Xie D., Fedarko N.S., Kuchel G.A. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 2008, 63:879-884.
48. Perez O.D., Nolan G.P. Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level. Immunol Rev 2006, 210:208-228.
49. Krutzik P.O., Nolan G.P. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytom A 2003, 55:61-70.
50. Sachs K., Perez O., Pe'er D., Lauffenburger D.A., Nolan G.P. Causal protein-signaling networks derived from multiparameter single-cell data. Science 2005, 308:523-529.
51. Wheelock A.M., Buckpitt A.R. Software-induced variance in two-dimensional gel electrophoresis image analysis. Electrophoresis 2005, 26:4508-4520.
52. Clark B.N., Gutstein H.B. The myth of automated, high-throughput two-dimensional gel analysis. Proteomics 2008, 8:1197-1203.
53. Berth M., Moser F.M., Kolbe M., Bernhardt J. The state of the art in the analysis of two-dimensional gel electrophoresis images. Appl Microbiol Biotechnol 2007, 76:1223-1243.
54. Anensen N., Haaland I., D'Santos C., Van Belle W., Gjertsen B.T. Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia. Curr Pharm Biotechnol 2006, 7:199-207.
55. Van Belle W., Anensen N., Haaland I., Bruserud O., Hogda K.A., Gjertsen B.T. Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables. BMC Bioinform 2006, 7:198.
56. Faergestad E.M., Rye M., Walczak B., Gidskehaug L., Wold J.P., Grove H., et al. Pixel-based analysis of multiple images for the identification of changes: a novel approach applied to unravel proteome patterns of 2-D electrophoresis gel images. Proteomics 2007, 7:3450-3461.
57. Spearman C. The proof and measurement of association between two rings. Am J Psychol 1904, 15:72-101.
58. Stein L.D. Towards a cyberinfrastructure for the biological sciences: progress, visions and challenges. Nat Rev Genet 2008, 9:678-688.
59. The Cancer Biomedical Informatics Grid (caBIG): infrastructure and applications for a worldwide research community. Stud Health Technol Inform 2007, 129:330-334.
60. Lee E.S., McDonald D.W., Anderson N., Tarczy-Hornoch P. Incorporating collaboratory concepts into informatics in support of translational interdisciplinary biomedical research. Int J Med Inform 2009, 78:10-21.
61. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80.
62. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98:5116-5121.
63. Geyer F.C., Reis J.S. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?. Int J Surg Pathol 2009, 17:285-302.
64. Anderssen E., Dyrstad K., Westad F. Reducing over-optimism in variable selection by cross-model validation. Chemom Intell Lab Syst 2006, 84:69-74.
65. Nguyen D.V., Rocke D.M. Tumor classification by partial least squares using microarray gene expression data. Bioinformatics 2002, 18:39-50.
66. Bovelstad H.M., Nygard S., Storvold H.L., Aldrin M., Borgan O., Frigessi A., et al. Predicting survival from microarray data-a comparative study. Bioinformatics 2007, 23:2080-2087.
67. Gidskehaug L., Anderssen E., Flatberg A., Alsberg B.K. A framework for significance analysis of gene expression data using dimension reduction methods. BMC Bioinform 2007, 8.
68. Smilde A.K., Westerhuis J.A., de Jong S. A framework for sequential multiblock component methods. J Chemometr 2003, 17:323-337.
69. Roe O.D., Anderssen E., Helge E., Pettersen C.H., Olsen K.S., Sandeck H., et al. Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype. PLoS ONE 2009, 4:e6554.
70. Kanehisa M., Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30.
71. Matthews L., Gopinath G., Gillespie M., Caudy M., Croft D., de Bono B., et al. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res 2009, 37:D619-D622.
72. Wasserman W.W., Sandelin A. Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet 2004, 5:276-287.
73. Wingender E., Dietze P., Karas H., Knuppel R. TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res 1996, 24:238-241.